Kim Ae Ra, Zou Yani, Kim Hyung Suk, Choi Jae Sue, Chang Gregory Youngnam, Kim You Jung, Chung Hae Young
College of Pharmacy, Pusan National University, Busan 609-735, Korea.
J Pharm Pharmacol. 2002 Oct;54(10):1385-92. doi: 10.1211/002235702760345473.
It has been known that reactive oxygen and nitrogen species such as nitric oxide (NO), superoxide radical (*O2-) and their byproduct peroxynitrite (ONOO-) induce cellular and tissue injury, ultimately resulting in several human diseases. In this study, we examined scavenging effects of 3-methyl-1,2-cyclopentanedione (MCP) from coffee extract on the reactivity of those toxic molecules. MCP significantly inhibited both the oxidation of 2,7-dichlorodihydrofluorescein diacetate (H2DCFDA) by reactive oxygen species (ROS) (mainly *O2-) from kidney homogenate (41% at 100 microM) and the generation of fluorescent 4,5-diaminofluorescein (DAF-2) by NO from sodium nitroprusside (IC50 (concn producing 50% inhibition), 63.8 microM). More potently, however, MCP suppressed the oxidation of dihydrorhodamine 123 (DHR 123) to fluorescent rhodamine 123 mediated by authentic ONOO- with an IC50 value of 3.3 microM. The neutralizing effect of the reactivity of ONOO- by MCP was due to electron donation, not nitration of the compound. Additionally, MCP also decreased ONOO- formation of nitrotyrosine adducts of glutathione (GSH) reductase, and consequently protected the enzyme activity of GSH reductase against decreasing by ONOO-, indicating that MCP may prevent ONOO- -induced damage of GSH reductase. Furthermore, MCP only weakly suppressed NO production, which is one of the upstream sources of ONOO- in-vivo, suggesting that NO production may be not a pharmacological target for MCP. Taken together, our results suggest that MCP may be regarded as a selective regulator of ONOO- -mediated diseases via direct scavenging activity of ONOO-.
已知活性氧和氮物种,如一氧化氮(NO)、超氧阴离子自由基(O2-)及其副产物过氧亚硝酸盐(ONOO-)会诱导细胞和组织损伤,最终导致多种人类疾病。在本研究中,我们检测了咖啡提取物中的3-甲基-1,2-环戊二酮(MCP)对这些有毒分子反应性的清除作用。MCP显著抑制了肾匀浆中活性氧(ROS)(主要是O2-)对2,7-二氯二氢荧光素二乙酸酯(H2DCFDA)的氧化作用(在100 microM时抑制率为41%)以及硝普钠产生的NO对荧光4,5-二氨基荧光素(DAF-2)的生成作用(IC50(产生50%抑制的浓度)为63.8 microM)。然而,更有效的是,MCP抑制了由纯ONOO-介导的二氢罗丹明123(DHR 123)氧化为荧光罗丹明123,IC50值为3.3 microM。MCP对ONOO-反应性的中和作用是由于电子供体作用,而非该化合物的硝化作用。此外,MCP还减少了谷胱甘肽(GSH)还原酶的硝基酪氨酸加合物的ONOO-形成,从而保护了GSH还原酶的酶活性不被ONOO-降低,这表明MCP可能预防ONOO-诱导的GSH还原酶损伤。此外,MCP仅微弱抑制NO的产生,而NO是体内ONOO-的上游来源之一,这表明NO产生可能不是MCP的药理学靶点。综上所述,我们的结果表明,MCP可能通过对ONOO-的直接清除活性被视为ONOO-介导疾病的选择性调节剂。